Northern Trust’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37M | Buy |
761,115
+523,467
| +220% | +$25.5M | 0.01% | 1278 |
|
|
2025
Q1 | $8.09M | Sell |
237,648
-19,520
| -8% | -$664K | ﹤0.01% | 2164 |
|
|
2024
Q4 | $10.1M | Buy |
257,168
+29,416
| +13% | +$1.16M | ﹤0.01% | 2112 |
|
|
2024
Q3 | $10.7M | Sell |
227,752
-5,659
| -2% | -$266K | ﹤0.01% | 2026 |
|
|
2024
Q2 | $12.6M | Sell |
233,411
-9,867
| -4% | -$533K | ﹤0.01% | 1858 |
|
|
2024
Q1 | $16.6M | Sell |
243,278
-7,155
| -3% | -$488K | ﹤0.01% | 1714 |
|
|
2023
Q4 | $15.7M | Buy |
250,433
+6,185
| +3% | +$387K | ﹤0.01% | 1789 |
|
|
2023
Q3 | $11.1M | Buy |
244,248
+5,085
| +2% | +$231K | ﹤0.01% | 1926 |
|
|
2023
Q2 | $13.4M | Buy |
239,163
+40,289
| +20% | +$2.26M | ﹤0.01% | 1858 |
|
|
2023
Q1 | $9M | Buy |
198,874
+10,232
| +5% | +$463K | ﹤0.01% | 2090 |
|
|
2022
Q4 | $7.67M | Sell |
188,642
-10,122
| -5% | -$411K | ﹤0.01% | 2189 |
|
|
2022
Q3 | $13M | Buy |
198,764
+14,533
| +8% | +$950K | ﹤0.01% | 1797 |
|
|
2022
Q2 | $11.2M | Buy |
184,231
+18,621
| +11% | +$1.13M | ﹤0.01% | 1945 |
|
|
2022
Q1 | $10.4M | Buy |
165,610
+122,302
| +282% | +$7.68M | ﹤0.01% | 2125 |
|
|
2021
Q4 | $3.28M | Buy |
43,308
+1,007
| +2% | +$76.3K | ﹤0.01% | 2963 |
|
|
2021
Q3 | $4.74M | Sell |
42,301
-10,180
| -19% | -$1.14M | ﹤0.01% | 2770 |
|
|
2021
Q2 | $8.5M | Sell |
52,481
-7,394
| -12% | -$1.2M | ﹤0.01% | 2486 |
|
|
2021
Q1 | $7.3M | Buy |
59,875
+11,962
| +25% | +$1.46M | ﹤0.01% | 2501 |
|
|
2020
Q4 | $7.34M | Buy |
47,913
+2,500
| +6% | +$383K | ﹤0.01% | 2450 |
|
|
2020
Q3 | $3.8M | Buy |
45,413
+5,344
| +13% | +$447K | ﹤0.01% | 2709 |
|
|
2020
Q2 | $2.95M | Buy |
40,069
+3,976
| +11% | +$292K | ﹤0.01% | 2822 |
|
|
2020
Q1 | $1.53M | Buy |
36,093
+2,039
| +6% | +$86.5K | ﹤0.01% | 3003 |
|
|
2019
Q4 | $2.07M | Buy |
34,054
+2,321
| +7% | +$141K | ﹤0.01% | 3115 |
|
|
2019
Q3 | $1.3M | Buy |
31,733
+655
| +2% | +$26.8K | ﹤0.01% | 3305 |
|
|
2019
Q2 | $1.46M | Buy |
31,078
+2,188
| +8% | +$103K | ﹤0.01% | 3215 |
|
|
2019
Q1 | $1.03M | Buy |
28,890
+6,683
| +30% | +$239K | ﹤0.01% | 3346 |
|
|
2018
Q4 | $634K | Sell |
22,207
-6,110
| -22% | -$174K | ﹤0.01% | 3501 |
|
|
2018
Q3 | $1.26M | Buy |
28,317
+4,196
| +17% | +$186K | ﹤0.01% | 3406 |
|
|
2018
Q2 | $1.42M | Buy |
24,121
+8,241
| +52% | +$484K | ﹤0.01% | 3365 |
|
|
2018
Q1 | $726K | Buy |
+15,880
| New | +$726K | ﹤0.01% | 3468 |
|